JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

NUF2 and NEK2 promote malignant progression of gallbladder cancer by remodeling the extracellular matrix

  • 0Hepatobiliary and Pancreatic Surgery and Liver Transplantation Center, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Carcinogenesis +

|

April 12, 2025

|

April 12, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

This study identifies NEK2 and NUF2 as key genes driving gallbladder cancer (GBC) progression. Targeting these genes could offer new therapeutic strategies for this challenging biliary tract malignancy.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genomics

Background

  • Gallbladder cancer (GBC) is the most common biliary tract malignancy, often diagnosed late with poor outcomes.
  • Limited research exists on genes driving GBC's malignant progression.
  • Identifying novel therapeutic targets is crucial for improving GBC patient prognosis.

Purpose Of The Study

  • To identify significant hub genes involved in gallbladder cancer pathogenesis.
  • To explore potential novel therapeutic targets for GBC treatment.

Main Methods

  • RNA-sequencing (RNA-seq) to identify differentially expressed genes (DEGs) in GBC tissues.
  • Analysis of clinical sequencing data and the GSE139682 dataset for consistent gene expression trends.
  • Protein-protein interaction (PPI) network analysis using Cytoscape to screen for hub genes.
  • Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses.
  • Validation of candidate genes (NEK2 and NUF2) in GBC tumor tissues and cell proliferation assays.

Main Results

  • 549 genes showed consistent expression trends across GBC datasets (155 upregulated, 394 downregulated).
  • Enrichment analyses indicated significant involvement of extracellular matrix (ECM) remodeling in GBC progression, impacting cell division.
  • 17 candidate hub genes were identified, with NEK2 and NUF2 found to be overexpressed in GBC.
  • NEK2 and NUF2 were validated as promoting GBC cell proliferation.

Conclusions

  • ECM remodeling plays a key role in gallbladder cancer malignant progression.
  • NEK2 and NUF2 are identified as significant hub genes promoting GBC.
  • NEK2 and NUF2 represent promising novel therapeutic targets for gallbladder cancer.

Keywords:

Related Concept Videos

The Tumor Microenvironment 02:17

6.5K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Metastasis 02:30

5.4K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

The Extracellular Matrix 01:29

8.7K

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...

Mitogens and the Cell Cycle 02:38

6.3K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Abnormal Proliferation 02:23

4.4K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Tumor Progression 02:07

6.2K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...